The strong allogeneic response to donor MHC molecules in transplantation an
d the weak response to tumor antigens represent two important and divergent
but potentially interactive immune responses. A patient's response to allo
geneic MHC molecules might promote an effective T-cell response to self MHC
-restricted tumor peptides and the possibilities for this are discussed her
e. These allogeneic responses might successfully be harnessed to promote th
e immune eradication of metastatic cancer.